Modulation of Retinoic Acid-induced Differentiation of Human Leukemia (HL-60) Cells by Serum Factors and Sphinganine

Cancer Research

Volumn 50, Issue 2, 1990, Pages 222-226

  Stevens, Victoria L ^a   Owens, Nancy E ^a   Kinkade, Joseph M ^a   Merrill, Alfred H ^a   Winton, Elliott F ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE C; RADIOISOTOPE; RETINOIC ACID; SPHINGANINE;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL STRAIN HL 60; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; SERUM;

BLOOD PHYSIOLOGY; CELL DIFFERENTIATION; HUMAN; LEUKEMIA, PROMYELOCYTIC, ACUTE; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; PROTEIN KINASE C; SPHINGOSINE; SUPEROXIDES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TETRADECANOYLPHORBOL ACETATE; TRETINOIN;

EID: 0025186723     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Koeffler, H. P. Induction of differentiation of human acute myelogenous leukemia cells:therapeutic implications. Blood, 62:709–721, 1983.
2. Marx, J. L. Human trials of new cancer therapy begin. Science (Wash. D. C), 236:778–779, 1987.
3. Koeffler, H. P., and Amatruda, T. T., III. The effect of retinoids on haemopoiesis: clinical and laboratory studies. Ciba Found. Symp., 113:252–267, 1985.
4. Breitman, T. R., Selonick, S. E., and Collins, S. J. Induction of differentiation of the human promyelocyte leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. USA, 77:2936–2940, 1980.
5. Strickland, S., and Mahdavi, V. The induction of differentiation in terato-carcinoma stem cells by retinoic acid. Cell, 15:393–403, 1978.
6. Breitman, T. R., Collins, S. J., and Keene, B. R. Terminal differentiation of human promyelocytic leukemia cells in primary culture in response to retinoic acid. Blood, 57:1000–1004, 1981.
7. Gold, E. J., Mertelsman, R. H., Itri, L. M., Gee, T., Arlin, Z., Kempin, S., Clarkson, B., and Moore, M. A. S. Phase I clinical trial of 13-cis-retinoic acid in myelodysplastic syndromes. Cancer Treat. Rep., 67:981–987, 1983.
8. Flynn, P. J., Miller, W. J., Weisdorf, D. C., Browning, R., and Branda, R. F. Retinoic acid treatment of acute promyelocyte leukemia:in vitro and in vivo observations. Blood, 62:1211–1217, 1983.
9. Meng-er, H., Yu-chen, Y., Shu-rong, C., Jin-ren, C., Jia-Xiang, L., Lin, Z., Long-jun, G., and Zhen-yi, W. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood, 72:567–572, 1988.
10. Lippman, S. M., Kessler, J. F., and Meyskens, F. L., Jr. Retinoids as preventive and therapeutic anticancer agents (part 1). Cancer Treat. Rep., 77:391–405, 1987.
11. Ishikura, H., Okazaki, T., Mochizuki, T., Izumi, Y., Tashima, M., Sawada, H., and Uchino, H. Effect of antimetabolites and thymidine blockage in the induction of differentiation of HL-60 cells by retinoic acid or la, 25-dihydroxyvitamin D3. Exp. Hematol., 13:981–988, 1985.
12. Hemmi, H., and Breitman, T. R. Combinations of recombinant human interferons and retinoic acid synergistically induce differentiation of the human promyelocytic leukemia cell line HL-60. Blood, 69, 501–507, 1987.
13. Imaizumi, M., and Breitman, T. R. A combination of a T cell-derived lymphokine differentiation-inducing activity and a physiologic concentration of retinoic acid induces HL-60 to differentiate to cells with functional chemotactic peptide receptors. Blood, 67:1273–1280, 1986.
14. Veigl, M. L., Sedwick, W. D., Niedel, J., and Branch, M. E. Induction of myeloid differentiation of HL-60 cells with naphthalene sulfonamide calmodulin antagonists. Cancer Res., 46:2300–2305, 1986.
15. Zylber-Katz, E., and Glazer, R. I. Phospholipid- and Ca2+-dependent protein kinase activity and protein phosphorylation patterns in the differentiation of human promyelocytic leukemia cell line HL-60. Cancer Res., 45:5159–5164, 1985.
16. Tyers, M., Rachubinski, R. A., Sartori, C. S., Harley, C. B., and Haslam, R. J. Induction of the 47 kDa platelet substrate of protein kinase C during differentiation of HL-60 cells. Biochem. J., 243:249–253, 1987.
17. Cope, F. O., Howard, B. D., and Boutwell, R. K. The in vitro characterization of the inhibition of mouse brain protein kinase-C by retinoids and their receptors. Experientia (Basel), 42:1023–1027, 1986.
18. Hesketh, J. E., Campbell, G. P., and Reeds, P. J. Rapid response of protein synthesis to insulin in 3T3 cells:effects of protein kinase C depletion and differences from the response to serum repletion. Biosci. Rep., 6:797–804, 1986.
19. Ways, D. K., Dodd, R. C., Gwynne, J. T., and Earp, H. S. Lipoprotein modulation of the intracellular localization of protein kinase C and alteration of phorbol ester-stimulated differentiation in the human monoblast U937 cell line. Cancer Res., 46:6049–6053, 1986.
20. Ebeling, J. G., Vandenbark, G. R., Kuhn, L. J., Ganong, B. R., Bell, R. M., and Niedel, J. E. Diacylglycerols mimic phorbol diester induction of leukemic cell differentiation. Proc. Natl. Acad. Sci. USA, 82:815–819, 1985.
21. Harris, P., and Ralph, P. Human leukemic models of myelomonocytic development:a review of the HL-60 and U937 cell lines. J. Leukocyte Biol., 57:407–422, 1985.
22. Collins, S. J., Gallo, R. C., and Gallagher, R. E. Continuous growth and differentiation of human myeloid leukaemia cells in suspension culture. Nature (Lond.), 270:347–349, 1977.
23. Dalton, W. T., Ahearn, M. J., McCredie, K. B., Freireich, E. J., Stass, S. A., and Trujillo, J. M. HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3. Blood, 71:242–247, 1988.
24. Hemmi, H., and Breitman, T. R. Induction of differentiation of the human promyelocytic cell line HL-60 and primary cultures of human leukemia cells:a model for clinical treatment. In: R. I. Glazer (ed.), Developments in Cancer Chemotherapy, pp. 247–280. Cleveland: CRC Press, 1984.
25. Merrill, A. H., Jr., and Stevens, V. L. Modulation of protein kinase C and diverse cell functions by sphingosine:a pharmacologically interesting compound linking sphingolipids and signal transduction. Biochim. Biophys. Acta, 1010:131–139, 1989.
26. Hannun, Y. A., Loomis, C. R., Merrill, A. H., Jr., and Bell, R. M. Sphingosine inhibition of protein kinase C and of phorbol dibutyrate binding in vitro and in human platelets. J. Biol. Chem., 261:12604–12609, 1986.
27. Wilson, E., Olcott, M. C., Bell, R. M., Merrill, A. H., Jr., and Lambeth, J. D. Inhibition of the oxidative burst in human neutrophils by sphingoid long-chain bases. Role of protein kinase C in activation of the burst. J. Biol. Chem., 261:12616–12623, 1986.
28. Nelson, D. H., and Murray, D. K. Sphingolipids inhibit insulin and phorbol ester stimulated uptake of 2-deoxyglucose. Biochem. Biophys. Res. Commun., 138:463–467, 1986.
29. Hall, F. L., Fernyhough, P., Ishi, D. N., and Vulliet, P. R. Suppression of nerve growth factor-directed neurite outgrowth in PC 12 cells by sphingosine, an inhibitor of protein kinase C. J. Biol. Chem., 263:4460–4466, 1988.
30. Nutter, L. M., Grill, S. P., Li, J., Tan, R., and Chen, Y. Induction of virus enzymes by phorbol esters and /i-butyrate in Epstein-Barr virus genome-carrying Raji cells. Cancer Res., 47:4407–4412, 1987.
31. Badwey, J. A., Robinson, J. M., Horn, W., Soberman, R. J., Karnovsky, M. J., and Karnovsky, M. L. Synergistic stimulation of neutrophils. Possible involvement of 5-hydroxy-6, 8, l 1, 14-eicosatetraenoate in superoxide release. J. Biol. Chem., 263:2779–2786, 1988.
32. SifTert, W., and Akkerman, J. W. N. Protein kinase C enhances Ca2+ mobilization in human platelets by activating Na/H exchange. J. Biol. Chem., 263:4223–4227, 1988.
33. Mclntyre, T. M., Reinhold, S. L., Prescott, S. M., and Zimmerman, G. A. Protein kinase C activity appears to be required for the synthesis of platelet-activating factor and leukotriene B4 by human neutrophils. J. Biol. Chem., 262:15370–15376, 1987.
34. Wiedmer, T., Ando, B., and Sims, P. J. Complement C5b-9-stimulated platelet secretion is associated with a Ca2-initiated activation of cellular protein kinases. J. Biol. Chem., 262:13674–13681, 1987.
35. Hannun, Y. A., Greenberg, C. S., and Bell, R. M. Sphingosine inhibition of agonist-dependent secretion and activation of human platelets implies that protein kinase C is a necessary and common event of the signal transduction pathways. J. Biol. Chem., 262:13620–13626, 1987.
36. Rider, L. G., Dougherty, R. W., and Niedel, J. E. Phorbol diesters and dioctanoylglycerol stimulate accumulation of both diacylglycerols and alky-lacylglycerols in human neutrophils. J. Immunol., 140:200–207, 1988.
37. Civan, M. M., Peterson-Yantorno, K., and O'Brien, T. G. Insulin and phorbol ester stimulate conductive Na transport through a common pathway. Proc. Natl. Acad. Sci. USA, 85:963–967, 1988.
38. Merrill, A. H., Jr., Sereni, A. M., Stevens, V. L., Hannun, Y. A., Bell, R. M., and Kinkade, J. M., Jr. Inhibition of phorbol ester-dependent differentiation of human promyelocyte leukemic (HL-60) cells by sphinganine and other long-chain bases. J. Biol. Chem., 261:12610–12615, 1986.
39. Rizzino, A., and Crowley, C. Growth and differentiation of embryonal carcinoma cell line F in defined media. Proc. Natl. Acad. Sci. USA, 77:457–461, 1980.
40. Ong, D. E., and Chytil, F. Retinoic acid-binding protein in rat tissue:partial purification and comparison of rat tissue retinol-binding protein. J. Biol. Chem., 250:6113–6117, 1980.
41. Brandt, S. J., Barnes, K. C., Glass, D. B., and Kinkade, J. M., Jr. Glucocor-tkoid-stimulated increase in chemotactic peptide receptors on differentiating human myeloid leukemia (HL-60) cells. Cancer Res., 47:4947–4951, 1981.
42. Skubitz, K. M., Zhen, Y., and August, J. T. Dexamethasone synergistically induces chemotactic peptide receptor expression in HL-60 cells. Blood, 59:586–593, 1982.
43. Uozumi, J., Imaizumi, M., and Breitman, T. R. The effects of serum albumin on retinoic acid (RA)-induced differentiation of HL60 (human promyelocytic leukemia) cells. Proc. Am. Assoc. Cancer Res., 27:44, 1986.
44. Yen, A., Reece, S. L., and Albright, K. L. Membrane origin for a signal eliciting a program of cell differentiation. Exp. Cell Res., 152:493–499, 1984.
45. Davies, P. J. A., Murtaugh, M. P., Moore, W. T., Johnson, G. S., and Lucas, D. Retinoic acid-induced expression of tissue transglutaminase in human promyelocytic leukemia (HL-60) cells. J. Biol. Chem., 260:5166–5174, 1985.
46. Barnes, D., and Sato, G. Methods for growth of cultured cells in serum-free medium. Anal. Biochem., 102: 255–270, 1980.
47. Honma, Y., Kasukabe, T., and Hozumi, M. Modification by serum of differentiation of cultured human myeloid cells in response to 12-O-tetrade-canoylphorbol-13-acetate. Gann, 75: 97–104, 1982.
48. Stevens, V. L., Winton, E. F., Smith, E. E., Owens, N. E., Kinkade, J. M., Jr., and Merrill, A. H., Jr. Differential effects of long-chain (sphingoid) bases on the monocytic differentiation of human leukemia (HL-60) cells induced by phorbol esters, la, 25-dihydroxyvitamin D3, or ganglioside GMs. Cancer Res., 49:3229–3234, 1989.
49. Fontana, J. A., Rogers, J. S., III, and Durham, J. P. The role of 13-cfr-retinoic acid in the remission induction of a patient with acute promyelocytic leukemia. Cancer (Phila.), 57:209–217, 1986.
50. Findley, H. W., Jr., Steuber, C. P., Ruymann, F. B., McKolanis, J. R., Williams, D. L., and Ragab, A. H. Effect of retinoic acid on myeloid antigen expression and clonal growth of leukemic cells from children with acute non-lymphocytic leukemia:a pediatric oncology group study. Leuk. Res., 10:43–50, 1986.